Jg. Fox et al., Helicobacter canadensis sp nov isolated from humans with diarrhea as an example of an emerging pathogen, J CLIN MICR, 38(7), 2000, pp. 2546-2549
We recently analyzed 11 helicobacter isolates cultured from diarrhea patien
ts in Canada. These isolates had been characterized biochemically by restri
ction fragment length polymorphism (RFLP; AluI, HhaI) analysis and by fatty
-acid analysis as Helicobacter pullorum. However, four of the isolates diff
ered biochemically from H. pullorum by their inability to hydrolyze indoxyl
acetate and their resistance to nalidixic acid. Using complete 16S rRNA an
alysis, we determined that these four strains clustered near H. pullorum bu
t had a sequence difference of 2% and therefore represent a novel helicobac
ter, Helicobacter canadensis. This novel helicobacter could also be disting
uished from Ii pullorum by RFLP analysis using ApaLI. The number of novel H
elicobacter spp, associated with gastrointestinal disease in humans and ani
mals is rapidly increasing. There are now six Helicobacter spp, isolated fr
om diarrheic humans, the other five being Ii. pullorum, Ii. canis, "H, rapp
ini," Ii fennelliae, and Ii cinaedi. This finding highlights the importance
of careful molecular analysis in addition to standard biochemical tests in
identifying the increasing number of Helicobacter spp, isolated from human
s and animals.